Menovazan ointment 40 g

Menovazan ointment 40 g

Menovazan is a combined drug and its properties are determined by the action of active components.

In particular, due to the selective effect of menthol on cold receptors, the ointment causes a feeling of cold, and the irritating effect can be changed by slight anesthesia. Reflexively, menthol changes the tone of blood vessels. This applies to both superficial vessels and vessels located deeper. Novocaine has a sufficiently pronounced anesthetic activity. It does not change the tone of blood vessels.

Anesthesin causes superficial anesthesia. The combination of the specified components in one preparation provides the ability to cause a reversible disturbance of the excitability and conductivity of nerve receptors and conductors upon direct contact with them, to exert an irritating and distracting effect, to suppress the excitation of nerve fiber membranes, to reduce the amplitude of the action potential, to increase the threshold of depolarization of the nerve fiber membrane, to slow down the speed development of the ascending phase of the action potential, reduce the degree of excitement in the nervous elements.

**Please note that this medication requires refrigeration. We ship it in special packaging with dry ice. To ensure the highest quality of the product, please select expedited shipping. If you choose standard shipping, USA Apteka is not responsible for maintaining the correct temperature of the product, and returns for this reason will not be accepted.

*We apologize for any inconvenience in case of the product being out of stock.
Please feel free to use this form to contact us, and we will notify you as soon as the item is available again.

Here's something that might pique your interest: 

Navigating Mental Health: The Role of Medication and Lifestyle Changes
In our blog, you can discover a wealth of fascinating and valuable information.

Thank you for choosing USA Apteka, your Russian pharmacy and trusted source for popular, favorite OTC products from Russia, Ukraine, and other CIS countries.